Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Holdings Lessened by Truist Financial Corp
Truist Financial Corp trimmed its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 13.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,686 shares of the biopharmaceutical company’s stock after selling 1,615 shares during the quarter. Truist Financial Corp’s holdings […]
Truist Financial Corp trimmed its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 13.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,686 shares of the biopharmaceutical company’s stock after selling 1,615 shares during the quarter. Truist Financial Corp’s holdings […]
